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INTRODUCTION 
Inosine monophosphate dehydrogenase (IMPDH; EC1.2.1.14) is a pivotal en- 
zyme in the purine metabolic pathway and regulates the synthesis of guanine ribonucle- 
otides from IMP (FIG. 1). This enzyme has been demonstrated to have higher levels 
of activity in proliferating cells and has thus served as a target for chemotherapeutic 
agents. Mizoribine (bredinin; Qcarbamoyl-l-P-D-nbofuranosylimidazolium) is an im- 
idazole nucleoside originally isolated from a soil fungus which has been shown to 
inhibit IMPDH and to deplete cultured cells of guanine ribonucleotides in p i t r ~ . ~ ~  Of 
interest is the fact that mizoribine has been used clinically in Japan as an immunosup 
pressive agent5 and has been shown in several experimental systems to have increased 
effectiveness when used in combination with cyclosporine.68 In view of the clinical 
efficacy of this drug, we have investigated the nature of its effects on peripheral blood 
T lymphocytes in order to answer the following questions: (1) Does mizoribine act 
by depleting T lymphocytes of guanine ribonucleotides? (2) What are the physiologic 
effects of guanine ribonucleotide depletion in these cells? and (3) Does 6mercaptopu- 
rine or azathioprine, both inhibitors of purine biosynthesis, inhibit T cell activation 
by the same mechanism(s)? 
METHODS 
Isofation and Culture of Peripheral Blood T Lymphocytes 
T lymphocytes were isolated from human peripheral blood mononuclear cells using 
negative selection with a cocktail of monoclonal antibodies as previously described9 
and were shown to contain greater than 95% CD2-positive cells by surface antigen 
staining before each experiment. Cells were stimulated to proliferate with phorbol 
myrisitate acetate (PMA) at a final concentration of 3 ng/ml and ionomycin at 125 
n g / d  or with anti-CD3 antibody immobilized at a concentration of 1 pg/d on goat 
anti-mouse antibodycoated culture dishes. T cells were incubated in RPMI 1640 tissue 
culture medium containing 10% fetal calf serum at a concentration of 1 x lo6 cells/ 
217 
218 ANNALS NEW YORK ACADEMY OF SCIENCES 
De Novo Purine Biosynthesis 
1 
L 
IMP Mizorbine Momphosphate 
4 









FIGURE 1. De mtr~ and salvage pathways of purine ribonucleotide biosynthesis: 1, adenylosucci- 
nate synthetase; 2, IMPDH; 3, adenine phosphoribosyltransferase; 4, hypoxanthine phosphori- 
bosyltransferase. 
ml, and proliferation was determined by measuring the incorporation of 1 pCi 
[3H]thymidine into DNA for 6 hours at the end of each culture period. Exogenous 
guanosine was supplied by adding the combination of guanosine and 8-aminoguano- 
s im9 Guanosine, 8-aminoguanosine, mycophenolic acid, azathioprine, and 6-mercap 
topurine were obtained from Sigma Chemical Co. (St. Louis, MO) and added at the 
final concentrations indicated. Mizoribine was obtained from Dr. K. Fukukawa, Asahi 
Chemical Co. (Tokyo, Japan). 
eel[ C’e Analysis 
106 cells from each experimental condition were fixed in ethanol and incubated 
with 18 pg/ml propidium iodide and 40 pg/ml RNase for 16 DNA content 
was measured within 24 hours on an Epics C cell sorter (Coulter Electronics, Inc.) 
and analysis of the cell cycle was performed using the Para 1 software program. 
Measurement of AlT  and GTP Pooh 
Nucleotide pools were measured by high-performance liquid chromatography us- 
ing a Partisil-10 SAX anion exchange column (Whatman, Clifton, NJ).l0 Nucleotide 
levels were quantitated by comparing areas under peaks absorbing at 254 nm with areas 
generated by nanomole amounts of pure standards. 
RESULTS 
Inhibition of Proliferation and Reduction in G21p Pools in T Lymphocytes 
Induced by &ribhe 
Treatment of isolated, purified human peripheral blood T cells with increasing 
doses of mizoribine resulted in a progressive decrease in the incorporation of [3H]thy- 
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TABLX I. Inhibition of T Cell Proliferation" Induced by PMA and Ionomycin or 
CD3 by Mizoribine 
PMA + 
Miwribine Ionomycin CD3 
(PU4  (cPm9 (CPm3 
0 43,716 t 6,466 167,630 t 14,566 
1 32,249 It 1,930 32,390 2 2,983 
5 14,918 2 1,096 19,192 5 612 
10 7,854 4 333 7,734 2 656 
50 866 t 125 611 zk 73 
a Proliferation is measured by the incorporation of lpCi of [3H]thymidine into DNA during 
the last 18 hours of a 72-hour culture. 
Mean * SD of quadruplicate determinations. 
midine into DNA, as shown in TABLE 1. The antiproliferative effect was observed in 
cells stimulated with monoclonal antibodies to CD3, as well as in cells stimulated with 
PMA and ionomycin, indicating that the effect was not dependent on cell membrane 
signaling events. FIGURE 2 demonstrates that T cell activation by PMA and ionomycin 
is associated with a progressive rise in GTP levels to a value of 5.8 times that of control 
levels at 72 hours (panel A). ATP levels increase three-fold over the same interval. 
Mizoribine at a concentration of 10 p g / d  reduced the total cellular GTP pool by 
approximately 50% at each time point of the culture (panel B), but did not reduce 
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FIGURE 2. Effect of mimribine on ATP and GTP pools during T cell stimulation with PMA 
and ionomycin. (A) Stimulation in the absence of mizoribine. (B) Stimulation in the presence 
of miwribine. 
220 ANNALS NEW YORK ACADEMY OF SCIENCES 
TABLE 2. Effect of Mizoribine on Cell Cycle Progression in T Lymphocytes 
Culture Conditions Go + GI S + G * + M  
Anti-CD3 
Anti-CD3 + Guo 
Anti-CD3 + Mizoribine 









NOTE: T lymphocytes were stimulated with anti-CD3 monoclonal antibody alone or in the 
presence of guanosine (50 pM), mizoribine (2 pg/ml), or both compounds. 
ATP pools or affect overall cell viability. Restoration of guanine ribonucleotide pools 
by the addition of 50 pM guanosine, a nucleoside that is converted to GMP by the 
salvage pathway (FIG. l), increased overall GTP pools to three times the baseline level 
at 72 hours.9 Comparison of the effects of mizoribine with those of azathioprine, 
6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine 
ribonucleotide pools demonstrated that guanosine completely prevented the inhibition 
of proliferation induced by mizoribine at concentrations up to and including 
10 pg/ml.9 
Effect of Guanine Ribonudeotide Depletion on the Cell Cyde 
In order to determine the effect of guanine ribonucleotide depletion on the cell 
cycle of T lymphocytes induced to proliferate from a resting state, we examined the 
expression of several genes that are sequentially expressed during T cell activation at 
the mRNA leveL9 The expression of the c-myc protooncogene, interleulun 2, and 
c-myb were unaffected at 6 or 24 hours in the presence of 10 pg/d mizoribine. Cell 
cycle analysis determined by measuring the DNA content of propoidium iodide- 
stained cells documented a partial block at the GI/S interface of the cell cycle with a 
mizoribine concentration of 2 pg/ml .  This block was reversible in the presence of 50 
pM guanosine, which repleted GTP pools (TABLE 2). We conclude from these studies 
that the antiproliferative effects of guanine ribonucleotide depletion are occurring at 
a point after many of the initial signal transduction events and at or near the point of 
initiation of DNA synthesis. 
Cornparikon of the E S e a  of IMP Dehydrogenase Wribitors with 
Those of Azathioprine or 6-Meraptopurine on T Lymphocyte 
Proliferation and Metabolism 
In order to determine definitively whether the effects of other immunosuppressive 
agents that interfere with purine biosynthesis also act by depletion of guanine ribonu- 
cleotide pools, we compared the effects of mizoribine with those of mycophenolic 
acid, a known specific inhibitor of IMPDH, 6mercaptopurine, and azathioprine. All 
four drugs were found to deplete GTP levels in T lymphocytes stimulated with PMA 
and ionomycin for 72 hours, and the GTP depletion was reversible in each case with 
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FIGURE 3. Comparison of the effects of IC5, concentrations of mizoribine, rnycophenolic 
acid, azathioprine, and hnercaptopurine on GTP pools in purified T lymphocytes after 72 hours 
of stimulation with PMA and ionomycin. *p < 0.05; tp < 0.01. Values are expressed as a 
percentage of those from untreated controls. 
the addition of guanosine (FIG. 3). The inhibition of proliferation seen with both 
mizoribine and mycophenolic acid was reversed with guanosine; however, the addition 
of guanosine to 6-mercaptopurine-treated cells only partially reversed the inhibition 
of proliferation, whereas it significantly increased the inhibition of proliferation in- 
duced by azathioprine (FIG. 4). The addition of both adenine and guanosine together 
was sufficient to restore full proliferation to 6-mercaptopurine-treated cells, but not 
to azathioprine-treated cells. These data indicate that the inhibitory effects of mizori- 
bine and mycophenolic acid on T lymphocyte proliferation are mediated primarily by 
the reduction in guanine ribonucleotide levels, whereas the effects of 6-mercaptopurine 
are mediated by combined adenine and guanine ribonucleotide depletion and those 
of azathioprine are unrelated to any effects on the purine ribonucleotide synthetic 
pathway. 
DISCUSSION 
We have determined that mizoribine, a commonly used immunosuppressive drug 
in Japan, leads to the depletion of guanine ribonucleotide pools in isolated human 
peripheral blood T lymphocytes and to concomitant inhibition of proliferation in 
response to both PWionomycin and anti-CD3 antibody. These findings, in conjunc- 
tion with the observation that both effects are reversed by the addition of guanosine 
to the cultures, support the conclusion that inhibition of IMP dehydrogenase by this 
drug may result in decreased T cell responses to stimulation through the CD3-T cell 
receptor complex. The precise mechanism leading to the inhibition of proliferation 
has not yet been established. Our data make it highly unlikely that GTP depletion is 
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FIGURE 4. Comparison of the effects ofATP and GTP repletion on T lymphocyte proliferation 
in the presence of IC, concentrations of azathioprine or 6mercaptopurine. Values represent the 
mean f SD of four determinations. 
inhibiting events early in the T cell activation pathway and support the concept that 
this metabolic perturbation is decting one or more events in the DNA synthetic 
pathway. It has been demonstrated that depletion of GTP is associated with a primary 
inhibition of DNA synthesis in murine S49 T lymphoma cells and that this effect 
cannot be accounted for by concomitant depletion of the dGTP but the 
nature of the GTP requirement remains obscure. Similarly, it is not yet clear why T 
lymphocytes might be particularly susceptible to the effects of IMPDH inhibition. 
This selectivity is suggested by the clinical observation that mizoribine at immunosup 
pressive doses does not have the myelosuppressive effect observed with other inhibitors 
of DNA synthesis such as methotrexate. Since the activation of peripheral blood T 
lymphocytes by mitogen or alloantigen involves the transition of a cell from a resting 
(Go) to a proliferating state, it is possible that the requirement for GTP is greater in 
these cells than in cells already engaged in the cell cycle, although this hypothesis has 
not yet been tested. Alternatively, the ability of these cells to compensate for GTP 
depletion induced by inhibitors of k mvo purine biosynthesis by using the salvage 
pathway (FIG. 1) may be less efficient. The use of highly selective inhibitors of IMPDH 
in vim in combination with detailed biochemical analysis of the lymphocytes from 
these individuals should shed further light on these issues. 
The observation that IMPDH inhibitors are associated with immunosuppression 
led us to askwhether either 6-mercaptopurine or azathioprine, which is rapidly metabo- 
lized to 6-MP and an imidazole moiety in vim, l3 might act by a similar biochemical 
mechanism. 6-MP is converted to 6-thioIMP, which has been shown to inhibit a 
number of purine biosynthetic enzymes including IMPDH.14 It thus seemed reason- 
able to ask whether inhibition of proliferation induced by these agents was similar to 
that induced by mizoribine or by mycophenolic acid. It is clear that neither of these 
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agents has any selectivity for IMPDH in intact cells, although both deplete GTP pools. 
In the case of azathioprine, the mechanism of inhibition of proliferation appears to 
be completely unrelated to its effect on purine biosynthesis and these data strongly 
implicate the imidazole moiety as a major factor in inhibiting T cell responsiveness. 
Of further interest is the observation that azathioprine must be added at or near the 
start of a 72-hour lymphocyte culture to maximally inhibit proliferation at ICs, doses.” 
This requirement contrasts markedly with the ability of IMPDH inhibitors to act 
within 24 hours of addition to already-stimulated T lymphocytes to inhibit prolifera- 
tion and suggests that there may be an additional role for these compounds once T 
cell activation has occurred. 
Finally, there are substantial data that cyclosporine at low doses may enhance the 
immunosuppressive effect of mizoribine in experimental a n i m a l ~ . ~ * J ~  Our previous 
experiments have demonstrated an additive effect of cyclosporine on the inhibition of 
T cell proliferation by mizoribine and the cumulative data clearIy suggest completely 
different mechanisms of action against T cells. It appears warranted to perform clinical 
trials using IMPDH inhibitors alone and in combination with reduced doses of 
cyclosporine in order to determine whether some of the toxic effects of cyclosporine 
can be attenuated. 
SUMMARY 
IMP dehydrogenase is a key enzyme in the a!e mvo pathway of purine biosynthesis 
and is responsible for catalyzing the first step in the formation of guanine ribonucleo- 
tides from inosine monophosphate. Mizoribine, an immunosuppressive agent in wide- 
spread clinical use in Japan, has been demonstrated to inhibit this enzyme. We have 
investigated the effects of mizoribine on human T cell activation. Stimulation of 
purified human peripheral blood T lymphocytes with phorbol ester and ionomycin 
leads to a five-fold increase in guanine ribonucleotide levels over 72 hours. The addition 
of mizoribine to these cultures at concentrations that are achieved in m’vo leads to a 
dose-dependent inhibition of proliferation and concomitant 50% decrease in guanine 
ribonucleotide levels, an effect that is reversible with the addition of guanosine, which 
repletes the GTP pool. Similar effects are Seen with direct stimulation via the CD%/T 
cell receptor complex. Inhibition of proliferation occurs at the Gl/S interface of the 
cell cycle and is additive to that produced by cyclosporine. In order to determine 
whether inhibition of IMP dehydrogenase is a common mechanism of immunosuppres- 
sion for drugs such as azathioprine and 6mercaptopurine that interfere with purine 
biosynthesis, we compared the effects of these agents on the metabolism of purified T 
lymphocytes. The results of these studies demonstrate that mizoribine and mycophe- 
nolic acid, a highly specific inhibitor of IMP dehydrogenase, inhibit proliferation 
directly by the depletion of guanine ribonucleotides; 6mercaptopurine, on the other 
hand, has a mixed effect on adenine and guanine ribonucleotide pools, whereas azathio- 
prine inhibits proliferation by a mechanism completely independent of its effects on 
the purine metabolic pathway. We conclude from these studies that inhibitors of IMP 
dehydrogenase have potential as specific immunosuppressive agents. 
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